U.S., July 10 -- ClinicalTrials.gov registry received information related to the study (NCT07693153) titled 'The Effects of Psilocybin on Social Connectedness' on July 03.
Brief Summary: The study is a randomized, double-blind, placebo-controlled, expectancy-controlled, mechanistic trial. This study looks to explore whether a single dose of psilocybin (25mg) reduces amygdala reactivity to negative socioemotional stimuli during the Facial Emotion Recognition Task (FERT) compared to a placebo in adults who feel lonely or those with unresolved grief symptoms.
Study Start Date: Aug. 31
Study Type: INTERVENTIONAL
Condition:
Loneliness
Grief
Intervention:
DRUG: Psilocybin
25 mg
DRUG: Placebo
Placebo capsule
Recruitment Status: NOT_YET_...